Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…
Read More
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
Read More
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Read More
Now arrived for recently graduated dermatologists: the JDD Welcome Kit! The Journal of Drugs in Dermatology (JDD), together with generous sponsors, has sent these curated kits to the newest members…
Read More
Background: The objective of this survey was to obtain feedback and insights from United States dermatology healthcare professionals on their perceptions of sunscreens. Methods: This cross-sectional survey study launched online…
Read More
Don’t lose platelets to the gel: simple tweaks boost PRP yield from thixotropic systems We are pulling out this must-read article from the vault. This brief report from the November…
Read More
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast's Steroid Stewardship Series,…
Read More
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability Warts are caused by non‑enveloped double‑stranded DNA human papillomaviruses and, while two‑thirds…
Read More
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Read More
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Read More
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…
Read More
Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,…
Read More
